These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 26781227

  • 1. Underuse of self-controlled designs in pharmacoepidemiology in electronic healthcare databases: a systematic review.
    Gault N, Castañeda-Sanabria J, Guillo S, Foulon S, Tubach F.
    Pharmacoepidemiol Drug Saf; 2016 Apr; 25(4):372-7. PubMed ID: 26781227
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice.
    Weldeselassie YG, Whitaker HJ, Farrington CP.
    Epidemiol Infect; 2011 Dec; 139(12):1805-17. PubMed ID: 21849099
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Case-crossover study design in pharmacoepidemiology: systematic review and recommendations.
    Consiglio GP, Burden AM, Maclure M, McCarthy L, Cadarette SM.
    Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1146-53. PubMed ID: 24030723
    [Abstract] [Full Text] [Related]

  • 10. Research on drug safety and effectiveness using pharmacoepidemiological databases.
    Andersen M.
    J Intern Med; 2014 Jun; 275(6):548-50. PubMed ID: 24635741
    [No Abstract] [Full Text] [Related]

  • 11. 'Why me?' versus 'why now?'--differences between operational hypotheses in case-control versus case-crossover studies.
    Maclure M.
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):850-3. PubMed ID: 17636552
    [No Abstract] [Full Text] [Related]

  • 12. Addressing unmeasured confounding in comparative observational research.
    Zhang X, Faries DE, Li H, Stamey JD, Imbens GW.
    Pharmacoepidemiol Drug Saf; 2018 Apr; 27(4):373-382. PubMed ID: 29383840
    [Abstract] [Full Text] [Related]

  • 13. A systematic review on the application of pharmacoepidemiology in assessing prescription drug-related adverse events in pediatrics.
    Luo X, Cappelleri JC, Frush K.
    Curr Med Res Opin; 2007 May; 23(5):1015-24. PubMed ID: 17526119
    [Abstract] [Full Text] [Related]

  • 14. Guidelines for good database selection and use in pharmacoepidemiology research.
    Hall GC, Sauer B, Bourke A, Brown JS, Reynolds MW, LoCasale R.
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21(1):1-10. PubMed ID: 22069180
    [Abstract] [Full Text] [Related]

  • 15. Methods to control for unmeasured confounding in pharmacoepidemiology: an overview.
    Uddin MJ, Groenwold RH, Ali MS, de Boer A, Roes KC, Chowdhury MA, Klungel OH.
    Int J Clin Pharm; 2016 Jun; 38(3):714-23. PubMed ID: 27091131
    [Abstract] [Full Text] [Related]

  • 16. A tutorial on the use of instrumental variables in pharmacoepidemiology.
    Ertefaie A, Small DS, Flory JH, Hennessy S.
    Pharmacoepidemiol Drug Saf; 2017 Apr; 26(4):357-367. PubMed ID: 28239929
    [Abstract] [Full Text] [Related]

  • 17. Design considerations in an active medical product safety monitoring system.
    Gagne JJ, Fireman B, Ryan PB, Maclure M, Gerhard T, Toh S, Rassen JA, Nelson JC, Schneeweiss S.
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():32-40. PubMed ID: 22262591
    [Abstract] [Full Text] [Related]

  • 18. Control yourself: ISPE-endorsed guidance in the application of self-controlled study designs in pharmacoepidemiology.
    Cadarette SM, Maclure M, Delaney JAC, Whitaker HJ, Hayes KN, Wang SV, Tadrous M, Gagne JJ, Consiglio GP, Hallas J.
    Pharmacoepidemiol Drug Saf; 2021 Jun; 30(6):671-684. PubMed ID: 33715267
    [Abstract] [Full Text] [Related]

  • 19. Methods in pharmacoepidemiology.
    Sommet A, Pariente A.
    Therapie; 2019 Apr; 74(2):187-197. PubMed ID: 30819408
    [Abstract] [Full Text] [Related]

  • 20. Pharmacoepidemiological safety studies in children: a systematic review.
    Osokogu OU, Dukanovic J, Ferrajolo C, Dodd C, Pacurariu AC, Bramer WM, 'tJong G, Weibel D, Sturkenboom MC, Kaguelidou F.
    Pharmacoepidemiol Drug Saf; 2016 Aug; 25(8):861-70. PubMed ID: 27255559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.